Related Experiment Video
Updated: Jul 2, 2026

Identification of Nucleolar Factors During HIV-1 Replication Through Rev Immunoprecipitation and Mass Spectrometry
Published on: June 26, 2019
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole
Gaël Champier1, Anthony Couvreux, Sébastien Hantz
1Université de Limoges, Faculté de Médecine, Centre Hospitalier Universitaire Dupuytren, EA 3175, Laboratoire de Bactériologie-Virologie-Hygiène, Centre National de Référence Cytomégalovirus, Limoges, France.
Background:
Benzimidazole D-ribonucleosides inhibit DNA packaging during human cytomegalovirus (HCMV) replication. Although they have been shown to target pUL56 and pUL89 (the large and small subunits of the HCMV terminase, respectively) their mechanism of action is not yet fully understood. We aimed here to better understand HCMV DNA maturation and the mechanism of action of benzimidazole derivatives.
Methods:
The HCMV pUL56 protein was studied by sequence analysis of the HCMV UL56 gene and herpesvirus counterparts combined with primary structure analysis of the corresponding amino acid sequences.
Results:
The UL56 sequence analysis of 45 HCMV strains and counterparts among herpesviruses allowed the identification of 12 conserved regions. Moreover, comparison with the product of gene 49 (gp49) of bacteriophage T4 suggested that the pUL56 zinc finger is localized close to the dimerization site of pUL56, providing a spatial organization of the catalytic site that allows recognition and cleavage of DNA.
Conclusions:
This study provides a basis to investigate the mechanism of concatemeric DNA cleavage and a biochemical basis for DNA packaging inhibition by benzimidazole derivatives.
Insights
Benzimidazole derivatives inhibit human cytomegalovirus (HCMV) DNA packaging by targeting the pUL56 protein. This study reveals conserved regions in pUL56, suggesting a mechanism for DNA cleavage and viral replication inhibition.
Area of Science:
- Virology
- Molecular Biology
- Biochemistry
Background:
- Benzimidazole D-ribonucleosides are known inhibitors of human cytomegalovirus (HCMV) DNA packaging.
- These compounds target the pUL56 and pUL89 subunits of the HCMV terminase complex.
- The precise mechanism of action for benzimidazole derivatives remains incompletely understood.
Purpose of the Study:
- To elucidate the mechanism of HCMV DNA maturation.
- To understand how benzimidazole derivatives inhibit viral replication.
- To investigate the role of the pUL56 protein in DNA packaging.
Main Methods:
- Sequence analysis of the HCMV UL56 gene and homologous genes in other herpesviruses.
- Primary structure analysis of the corresponding amino acid sequences.
- Comparative analysis with bacteriophage T4 gene 49 product (gp49).
Main Results:
- Identification of 12 conserved regions within the UL56 gene across 45 HCMV strains and herpesvirus relatives.
- Structural insights suggest the pUL56 zinc finger is spatially organized near the dimerization site.
- This organization is proposed to facilitate DNA recognition and cleavage by the terminase complex.
Conclusions:
- Provides a foundation for investigating the mechanism of concatemeric viral DNA cleavage.
- Establishes a biochemical basis for the inhibition of DNA packaging by benzimidazole derivatives.
- Offers potential targets for antiviral drug development against HCMV.
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Inhibitors Of Virion Release
Inhibitors of Viral Protein Synthesis
Cytomegalovirus Disease
Antiviral Nucleoside Inhibitors
Leaky Scanning

